Synergy between RU 28965 (roxithromycin) and human neutrophils for bactericidal activity in vitro.
The in vitro effects of RU 28965 (roxithromycin), a new semisynthetic macrolide, on human neutrophil activity were compared with those of erythromycin. RU 28965, at a concentration as low as 0.1 microgram/ml, significantly enhanced the phagocytosis and killing of Staphylococcus aureus by neutrophils...
Na minha lista:
| Publicado no: | Antimicrob Agents Chemother |
|---|---|
| Principais autores: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
American Society for Microbiology (ASM)
1986
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC176451/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/3019233/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.30.1.137 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|